| CYHB2250704 | 注射用地西他滨 | decitabine | Lyophilized | Chemical Drugs | Supplementary Application | 2022-11-11 | | Shandong New Time Pharmaceutical Co Ltd | | | view |
| CYHB2250702 | 注射用地西他滨 | decitabine | Lyophilized | Chemical Drugs | Supplementary Application | 2022-11-11 | | Shandong New Time Pharmaceutical Co Ltd | | | view |
| CYHB2250703 | 注射用地西他滨 | decitabine | Lyophilized | Chemical Drugs | Supplementary Application | 2022-11-11 | | Shandong New Time Pharmaceutical Co Ltd | | | view |
| CYHS2201724 | 注射用地西他滨 | decitabine | Lyophilized | Chemical Drugs(4) | Generic Drug | 2022-10-13 | | Sichuan Huiyu Pharmaceutical Co Ltd | | | view |
| CYHS2201723 | 注射用地西他滨 | decitabine | Lyophilized | Chemical Drugs(4) | Generic Drug | 2022-10-13 | | Sichuan Huiyu Pharmaceutical Co Ltd | | | view |
| JYHB2200127 | 注射用地西他滨 | decitabine | Lyophilized | Chemical Drugs | Supplementary Application | 2022-03-14 | | BSP Pharmaceuticals Srl;Janssen-Cilag International NV | | | view |
| JYHB2101305 | 注射用地西他滨 | decitabine | Lyophilized | Chemical Drugs | Supplementary Application | 2021-08-11 | | BSP Pharmaceuticals Srl;Janssen-Cilag International NV | | | view |
| CYHB2100321 | 注射用地西他滨 | decitabine | Lyophilized | Chemical Drugs(原6) | Supplementary Application | 2021-03-17 | 正大天晴药业集团南京顺欣制药有限公司 | Nanjing Shunxin Pharmaceuticals Co LTDof Chiatai Tianqing Pharmaceutical Group | In Review | 2021-03-16 | view |
| CYHB2100320 | 注射用地西他滨 | decitabine | Lyophilized | Chemical Drugs(原6) | Supplementary Application | 2021-03-17 | 正大天晴药业集团南京顺欣制药有限公司 | Nanjing Shunxin Pharmaceuticals Co LTDof Chiatai Tianqing Pharmaceutical Group | In Review | 2021-03-16 | view |
| CYHB2100322 | 注射用地西他滨 | decitabine | Lyophilized | Chemical Drugs(原6) | Supplementary Application | 2021-03-17 | 正大天晴药业集团南京顺欣制药有限公司 | Nanjing Shunxin Pharmaceuticals Co LTDof Chiatai Tianqing Pharmaceutical Group | In Review | 2021-03-16 | view |
| CYHS2000866 | 注射用地西他滨 | decitabine | Lyophilized | Chemical Drugs(4) | Generic Drug | 2020-12-16 | 健进制药有限公司 | Sagent (China) Pharmaceuticals Co Ltd | In Review | 2020-12-14 | view |
| CYHB2050630 | 注射用地西他滨 | decitabine | Lyophilized | Chemical Drugs | Supplementary Application | 2020-10-17 | 杭州中美华东制药有限公司 | Hangzhou Zhongmei Huadong Pharmaceutical Co Ltd | In Review | 2020-10-16 | view |
| JYHB2001392 | 注射用地西他滨 | decitabine | Lyophilized | Chemical Drugs | Supplementary Application | 2020-08-21 | 西安杨森制药有限公司 | Xian Janssen Pharmaceutical Ltd;Janssen-Cilag International NV;Pharmachemie BV | Certificate Issued | 2020-11-17 | view |
| CYHB2050177 | 注射用地西他滨 | decitabine | Lyophilized | Chemical Drugs | Supplementary Application | 2020-03-24 | 江苏奥赛康药业有限公司 | Jiangsu Aosaikang Pharmaceutical Co Ltd | In Review | 2020-03-23 | view |
| CYHB2050176 | 注射用地西他滨 | decitabine | Lyophilized | Chemical Drugs | Supplementary Application | 2020-03-24 | 江苏奥赛康药业有限公司 | Jiangsu Aosaikang Pharmaceutical Co Ltd | In Review | 2020-03-23 | view |
| JYHB1901423 | 注射用地西他滨 | decitabine | Lyophilized | Chemical Drugs | Supplementary Application | 2019-12-11 | Janssen Pharmaceutica N.V. | Johnson & Johnson Innovative Medicine;BSP Pharmaceuticals Srl;Janssen-Cilag International NV | In Review | 2019-12-10 | view |
| JYHB1901419 | 注射用地西他滨 | decitabine | Lyophilized | Chemical Drugs | Supplementary Application | 2019-12-11 | Janssen-Cilag International NV | Janssen-Cilag International NV;Pharmachemie BV | Certificate Issued | 2020-01-22 | view |
| JYHB1901418 | 注射用地西他滨 | decitabine | Lyophilized | Chemical Drugs | Supplementary Application | 2019-11-23 | Janssen-Cilag International NV | Janssen-Cilag International NV;Pharmachemie BV | Filed | 2019-11-28 | view |
| CYHB1950634 | 注射用地西他滨 | decitabine | Lyophilized | Chemical Drugs | Supplementary Application | 2019-09-11 | 正大天晴药业集团股份有限公司 | Jiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd | Approval Completed-Pending Certificated | 2022-01-25 | view |
| CYHB1950327 | 注射用地西他滨 | decitabine | Lyophilized | Chemical Drugs | Supplementary Application | 2019-04-30 | 江苏豪森药业集团有限公司 | Jiangsu Hansoh Pharmaceutical Group Co Ltd | Certificate Issued | 2021-03-03 | view |
